全球精準醫療市場

全球精準醫療市場規模預計將從2023年的542億美元成長到2028年的1005億美元，預測期內年複合成長率為13.2%。

按地區分類，北美市場預計將從2023年的226億美元成長到2028年的421億美元，年複合成長率為13.2%。歐洲市場預計將從2023年的141億美元成長到2028年的264億美元，年複合成長率為13.4%。

本報告調查了全球精準醫療市場，並提供了市場概況、市場影響因素和市場機會分析、市場規模趨勢和預測、各個細分市場和地區的詳細分析、技術趨勢、ESG 發展和形勢、主要企業簡介等

目錄

第1章 簡介

第2章 總結、要點

第3章 市場概述、定義

第4章 市場動態

• 市場促進因素
• 個人化醫療需求不斷成長
• 技術進步
• 政府舉措
• 慢性病患病率增加
• 市場課題
• 解釋資料
• 資料隱私
• 精準醫療的成本

第5章 精準醫療市場：按技術分類

• 巨量資料分析
• 生物資訊學
• 基因測序
• 藥物研發
• 伴隨診斷

第6章 精準醫療市場：按用途

• 瘤
• 中樞神經系統
• 免疫
• 呼吸系統疾病

第7章 精準醫療市場：按地區

• 北美
• 歐洲
• 亞太地區
• 南美洲
• 中東、非洲

第8章 新興技術

第9章 併購

第10章 競爭資訊

• 世界公司排名

第11章 公司簡介

• 2BPRECISE
• ABBVIE INC.
• AMGEN INC.
• ASTRAZENECA
• BRISTOL-MYERS SQUIBB CO.
• CATALENT INC.
• CLINISYS
• F. HOFFMANN-LA ROCHE LTD.
• FABRIC GENOMICS
• HUMAN LONGEVITY INC.
• IQVIA HOLDINGS INC.
• JOHNSON & JOHNSON
• LIFEOMIC HOLDINGS LLC
• LONZA
• MERCK & CO. INC.
• NOVARTIS AG
• PAREXEL INTERNATIONAL CORP.
• PFIZER INC.
• SOPHIA GENETICS
• SYAPSE INC.
• THERMO FISHER SCIENTIFIC INC.

Highlights:

The global market for precision medicine is estimated to increase from $54.2 billion in 2023 to reach $100.5 billion by 2028, at a compound annual growth rate (CAGR) of 13.2% from 2023 through 2028.

North American market for precision medicine is estimated to increase from $22.6 billion in 2023 to reach $42.1 billion by 2028, at a compound annual growth rate (CAGR) of 13.2% from 2023 through 2028.

European market for precision medicine is estimated to increase from $14.1 billion in 2023 to reach $26.4 billion by 2028, at a compound annual growth rate (CAGR) of 13.4% from 2023 through 2028.

Report Scope:

This study offers a global view of the solutions provided by precision medicine in the market. This report analyzes and assesses technologies such as big data analytics, bioinformatics, gene sequencing, drug discovery, companion diagnostics, and others. It also provides information about the areas in which precision medicine is used, such as oncology, central nervous system disorders, immunology, respiratory conditions, and others.

BCC Research analyzes and makes projections for each market and its segmentation and assesses the regulatory environment, pipeline products, and future aspects. The report also examines the impact of COVID, discusses emerging trends in the market, and profiles leading companies in the precision medicine market such as Pfizer, Roche, AstraZeneca, Novartis, and Thermo Fisher Scientific. The report covers the major markets of North America and Europe and emerging markets such as India, China, Japan, South America, and others.

Report Includes:

• 26 tables
• A comprehensive overview and an up-to-date analysis of the global market for precision medicine
• Analyses of the global market trends, with market revenue data (sales figures) for 2020-2022, forecasts for 2023, and projections of compound annual growth rates (CAGRs) through 2028
• Discussion of industry growth driving factors and major technology issues and challenges affecting the market for precision medicine as a basis for projecting demand in the next few years (2023-2028)
• Estimation of the actual market size and revenue forecast for global precision medicine market in USD million values, and corresponding market share analysis by technology type, application, end user, and region
• Insights into the recent industry structure for precision medicine technologies, competitive aspects of each product segments, increasing investment on R&D activities, market growth strategies, and company revenue share analysis
• Review of the recent patent grants and patent applications on precision medicine technologies
• Updated information on key mergers and acquisition deals, agreements, partnerships, collaborations and product launches within the global precision medicine industry
• Identification of the major stakeholders and analysis of the company competitive landscape based on their recent developments, financial performance, and segmental revenues
• Detailed company profiles of the leading market players, including AstraZeneca, Bristol-Myers Squibb Co., Novartis AG, Pfizer Inc., and Johnson & Johnson

Table of Contents

Chapter 1 Introduction

• Study Goals and Objectives
• Reasons for Doing This Study
• Scope of Report
• Methodology
• Information Sources
• Geographic Breakdown

Chapter 2 Summary and Highlights

• Market Outlook
• Market Summary

Chapter 3 Market Overview and Definition

• Definition
• Overview

Chapter 4 Market Dynamics

• Market Drivers
• Growing Demand for Personalized Medicine
• Technological Advancement
• Government Initiatives
• Rise in Chronic Disease Prevalence
• Market Challenges
• Data Interpretation
• Data Privacy
• Cost of Precision Medicine

Chapter 5 Precision Medicine Market by Technology

• Big Data Analytics
• Bioinformatics
• Gene Sequencing
• Drug Discovery
• Companion Diagnostics

Chapter 6 Precision Medicine Market by Application

• Oncology
• Central Nervous System
• Immunology
• Respiratory Disease

Chapter 7 Precision Medicine Market by Region

• North America
• Europe
• Asia-Pacific
• South America
• Middle East and Africa

Chapter 8 Emerging Technologies

• Emerging Technology in Precision Medicine

Chapter 9 Merger and Acquisitions

• Mergers and Acquisitions

Chapter 10 Competitive Intelligence

• Global Company Ranking

Chapter 11 Company Profiles

• 2BPRECISE
• ABBVIE INC.
• AMGEN INC.
• ASTRAZENECA
• BRISTOL-MYERS SQUIBB CO.
• CATALENT INC.
• CLINISYS
• F. HOFFMANN-LA ROCHE LTD.
• FABRIC GENOMICS
• HUMAN LONGEVITY INC.
• IQVIA HOLDINGS INC.
• JOHNSON & JOHNSON
• LIFEOMIC HOLDINGS LLC
• LONZA
• MERCK & CO. INC.
• NOVARTIS AG
• PAREXEL INTERNATIONAL CORP.
• PFIZER INC.
• SOPHIA GENETICS
• SYAPSE INC.
• THERMO FISHER SCIENTIFIC INC.

List of Tables

• Summary Table : Global Market for Precision Medicine, by Region, Through 2028
• Table 1 : Global Market for Precision Medicine, by Technology, Through 2028
• Table 2 : Global Market for Precision Medicine, by Application, Through 2028
• Table 3 : Global Market for Precision Medicine, by Region, Through 2028
• Table 4 : North American Market for Precision Medicine, by Country, Through 2028
• Table 5 : North American Market for Precision Medicine, by Technology, Through 2028
• Table 6 : North American Market for Precision Medicine, by Application, Through 2028
• Table 7 : European Market for Precision Medicine, by Country, Through 2028
• Table 8 : European Market for Precision Medicine, by Technology, Through 2028
• Table 9 : European Market for Precision Medicine, by Application, Through 2028
• Table 10 : Asia-Pacific Market for Precision Medicine, by Country, Through 2028
• Table 11 : Asia-Pacific Market for Precision Medicine, by Technology, Through 2028
• Table 12 : Asia-Pacific Market for Precision Medicine, by Application, Through 2028
• Table 13 : South American Market for Precision Medicine, by Technology, Through 2028
• Table 14 : South American Market for Precision Medicine, by Application, Through 2028
• Table 15 : Middle East and African Market for Precision Medicine, by Technology, Through 2028
• Table 16 : Middle East and African Market for Precision Medicine, by Application, Through 2028
• Table 17 : Global Market Rankings for Precision Medicine, by Company, 2022
• Table 18 : Amgen Inc.: Revenue, 2020-2022
• Table 19 : AstraZeneca: Revenue, 2020-2022
• Table 20 : AstraZeneca: Revenue, by Segment (Product Sales), 2020-2022
• Table 21 : Bristol-Myers Squibb Co.: Revenue, 2020-2022
• Table 22 : Catalent Inc.: Revenue, 2020-2022
• Table 23 : Johnson & Johnson: Revenue, 2020-2022
• Table 24 : Novartis AG: Revenue, 2020-2022
• Table 25 : Pfizer Inc.: Revenue, 2020-2022

List of Figures

• Summary Figure : Global Market for Precision Medicine, by Region, 2020-2028
• Figure 1 : Global Heart and Circulatory Disease Prevalence, 2021
• Figure 2 : Big Data Analytics in Personalized Medicine
• Figure 3 : Outline of Precision Medicine in Oncology
• Figure 4 : Common Clinical Phenotypes in Neurodegenerative and Neuropsychiatric Disorders
• Figure 5 : AstraZeneca: Revenue Share, by Therapy Area, 2022
• Figure 6 : AstraZeneca: Revenue Share, by Reporting Region, 2022
• Figure 7 : Bristol-Myers Squibb Co.: Revenue Share, by Region, 2022
• Figure 8 : Novartis AG: Revenue Share, by Region, 2022
• Figure 9 : Pfizer Inc.: Revenue Share, by Country, 2022